IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.624
EU - Europa 18.487
AS - Asia 9.838
SA - Sud America 2.300
AF - Africa 320
Continente sconosciuto - Info sul continente non disponibili 73
OC - Oceania 30
Totale 49.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.277
IE - Irlanda 5.564
SG - Singapore 3.068
DE - Germania 2.826
HK - Hong Kong 2.720
SE - Svezia 2.674
UA - Ucraina 2.190
CN - Cina 1.926
BR - Brasile 1.855
RU - Federazione Russa 1.468
IT - Italia 1.454
FI - Finlandia 1.190
VN - Vietnam 845
GB - Regno Unito 426
IN - India 353
KR - Corea 317
CA - Canada 201
FR - Francia 178
AR - Argentina 171
ID - Indonesia 110
MX - Messico 104
BJ - Benin 103
ZA - Sudafrica 98
BD - Bangladesh 95
EC - Ecuador 83
NL - Olanda 78
PL - Polonia 74
EU - Europa 70
IR - Iran 68
AT - Austria 65
JP - Giappone 63
TR - Turchia 58
BE - Belgio 55
ES - Italia 55
CZ - Repubblica Ceca 54
LT - Lituania 49
CO - Colombia 48
PY - Paraguay 39
IQ - Iraq 35
VE - Venezuela 35
EG - Egitto 27
CL - Cile 26
PE - Perù 25
SY - Repubblica araba siriana 21
MA - Marocco 20
AU - Australia 19
PK - Pakistan 18
KE - Kenya 17
DZ - Algeria 16
RO - Romania 15
UZ - Uzbekistan 15
MY - Malesia 14
SA - Arabia Saudita 14
BG - Bulgaria 13
IL - Israele 13
UY - Uruguay 13
TN - Tunisia 12
DO - Repubblica Dominicana 11
AE - Emirati Arabi Uniti 10
AL - Albania 9
CH - Svizzera 9
ET - Etiopia 9
JO - Giordania 9
NZ - Nuova Zelanda 9
AZ - Azerbaigian 7
KZ - Kazakistan 7
NP - Nepal 7
HR - Croazia 6
KG - Kirghizistan 6
TW - Taiwan 6
BH - Bahrain 5
HN - Honduras 5
RS - Serbia 5
TT - Trinidad e Tobago 5
CI - Costa d'Avorio 4
DK - Danimarca 4
JM - Giamaica 4
LB - Libano 4
MK - Macedonia 4
NG - Nigeria 4
AM - Armenia 3
BN - Brunei Darussalam 3
GE - Georgia 3
GR - Grecia 3
KW - Kuwait 3
LU - Lussemburgo 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
CR - Costa Rica 2
GT - Guatemala 2
GY - Guiana 2
Totale 49.641
Salva come PNG Salva come JPEG
Città #
Dublin 5.548
Jacksonville 3.929
Hong Kong 2.717
Dearborn 1.869
Chandler 1.333
Wilmington 1.277
Beijing 994
Singapore 777
Lawrence 733
Princeton 732
Ashburn 669
Moscow 608
San Mateo 564
Los Angeles 472
Andover 379
Piemonte 371
Buffalo 351
Ho Chi Minh City 316
Seoul 314
Boardman 313
Ann Arbor 301
Woodbridge 199
Houston 191
Hanoi 168
Novara 165
São Paulo 159
Munich 142
Redondo Beach 142
New York 138
Hefei 135
Dallas 131
Philadelphia 116
Düsseldorf 115
Helsinki 109
Nanjing 109
Cotonou 103
Bremen 102
Kunming 98
Norwalk 91
Grafing 80
Frankfurt am Main 73
Milan 72
Toronto 64
Montreal 60
London 59
Rio de Janeiro 58
Brooklyn 57
Warsaw 57
Tokyo 55
Denver 53
Nuremberg 53
Seattle 53
Jinan 52
Johannesburg 52
Mexico City 51
Brussels 50
Chennai 50
Fairfield 50
Poplar 50
Santa Clara 50
Stockholm 47
Atlanta 46
Guangzhou 43
Turin 43
Curitiba 42
Brno 41
Belo Horizonte 39
Chicago 38
Phoenix 38
Nanchang 37
Falkenstein 36
Brasília 35
Boston 34
Orem 34
Rome 33
Haiphong 32
Vienna 31
Porto Alegre 30
Jakarta 29
Mumbai 29
Turku 29
Da Nang 28
San Francisco 28
Zanjan 28
Manchester 27
Thái Bình 27
Guayaquil 26
Quito 25
Amsterdam 24
Dhaka 24
Falls Church 24
Ankara 23
Biên Hòa 23
Shenyang 23
Campinas 21
Fuzhou 21
Leawood 20
Fortaleza 19
Ninh Bình 19
Ottawa 19
Totale 29.394
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 199
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 182
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 171
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 158
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 145
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 139
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 135
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 135
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 133
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 126
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 123
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 123
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 122
The clinical implications of gene mutations in chronic lymphocytic leukaemia 121
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 120
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 118
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 117
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 116
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 116
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 115
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 113
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 111
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 107
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 107
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 106
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 105
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 105
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 105
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 104
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 104
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 103
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 102
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 100
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 99
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 99
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 99
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 99
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 98
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 98
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 98
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 98
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 98
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 98
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 97
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 97
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 97
Factor VIII as a potential player in cancer pathophysiology 97
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 96
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 96
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 96
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 96
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 95
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 95
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 95
Biology and treatment of Richter syndrome 95
European education corridors: opportunity for academic solidarity 95
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 93
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 93
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 92
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 92
Absence of NOTCH1 gene mutations in MALT lymphomas 92
The genetics of nodal marginal zone lymphoma 92
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 91
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 91
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 91
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 91
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 91
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 90
KAPOSI's SARCOMA-ASSOCIATED HERPESVIRUS DNA SEQUENCES IN AIDS-RELATED AND AIDS-UNRELATED LYMPHOMATOUS EFFUSIONS 90
HIV-ASSOCIATED HHV-8 POSITIVE PRIMARY LYMPHOMATOUS EFFUSIONS: RADIOLOGICAL FINDINGS IN SIX PATIENTS 90
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 90
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 90
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 90
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 89
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. 89
SAC I RFLP IN THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR GENE (IGF2R) ON HUMAN CHROMOSOME 6q 89
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 89
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 89
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 89
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 89
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 89
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 89
ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES FROM LYMPHOMATOUS EFFUSIONS 88
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 88
Genetic determinants of response to warfarin. 88
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 88
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 88
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 87
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 87
Targeting p53 in chronic lymphocytic leukemia 87
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group 86
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 86
Potential of BCL2 as a target for chronic lymphocytic leukemia treatment 86
DIAGNOSI E CLASSIFICAZIONE DEI LINFOMI NON-HODGKIN. BASI PATOLOGICHE, FENOTIPICHE E MOLECOLARI 85
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma 85
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 85
Genetic determinants of response to warfarin. 85
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 85
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. 85
Totale 10.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 299.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 299.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.177 0 0 0 0 640 54 707 33 710 66 826 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/20268.448 1.029 893 2.116 3.717 693 0 0 0 0 0 0 0
Totale 50.499